Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Study Overview
=================
Brief Summary
-----------------
This study will include 100 patients with Type 1 and Type 2 diabetes, split into 2 groups of 50 patients according to their behaviour type, and their adaptation to different factors of stress encountered in their lives: the first group will consist of patients with a characteristic Type A behaviour profile, that is to say patients with a proactive, impatient behaviour pattern the second group will consist of patients with a characteristic Type B behaviour profile that is to say patients with a calm, slow behaviour pattern The objective is to know if the different behaviour patterns are associated with distinct biological markers likely to influence the evolution of the diabetes. Participation in this study will be approximately 1h30, patients will participate ONCE ONLY: they will answer simple questions about their disease and then complete 3 questionnaires each with 14 items. they will meet a clinical psychologist for an interview lasting approximately 45 minutes recorded on an audio recorder. The consultation will be used to seek links between the psyche and the disease. they will provide one blood sample of 12 ml (equivalent to a soup spoon) drawn in the morning.

Official Title
-----------------
Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Conditions
-----------------
Patients With a Type A or B Behaviour Profile, Patients With Type 1 or Type 2 Diabetes

Intervention / Treatment
-----------------
* Other: Blood sample of 12 ml


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients who have provided written informed consent Patients with type 1 or type 2 diabetes Patient admitted for a consultation, as out or in-patients to the Endocrinology-Diabetology-Metabolic diseases department of Dijon CHU Patient > 18 years Patient with either a characteristic Type A behaviour profile (Bortner > 210), or a characteristic Type B behaviour profile (Bortner<154) Exclusion Criteria: Persons not covered by national health insurance Adults under guardianship or wards of court or not intellectually independent Patients without diabetes Patients with a mixed A/B behaviour profile (154< Bortner score <210) Pregnant or breast-feeding women

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: Type A behaviour profile<br> | Other: Blood sample of 12 ml<br> <br> |
| Other: Type B behaviour profile<br> | Other: Blood sample of 12 ml<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Telomere length |  | Baselines | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Level of expression of candidate genes |  | Baselines |